Correlation Between Edgewise Therapeutics and Relmada Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Relmada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Relmada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Relmada Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Relmada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Relmada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Relmada Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Relmada Therapeutics
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Edgewise and Relmada is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Relmada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relmada Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Relmada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relmada Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Relmada Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Relmada Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.79 times more return on investment than Relmada Therapeutics. However, Edgewise Therapeutics is 1.27 times less risky than Relmada Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Relmada Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 853.00 in Edgewise Therapeutics on September 14, 2024 and sell it today you would earn a total of 1,950 from holding Edgewise Therapeutics or generate 228.6% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Edgewise Therapeutics vs. Relmada Therapeutics
Performance |
Timeline |
Edgewise Therapeutics |
Relmada Therapeutics |
Edgewise Therapeutics and Relmada Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Edgewise Therapeutics and Relmada Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Relmada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Relmada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relmada Therapeutics will offset losses from the drop in Relmada Therapeutics' long position.Edgewise Therapeutics vs. Puma Biotechnology | Edgewise Therapeutics vs. Iovance Biotherapeutics | Edgewise Therapeutics vs. Day One Biopharmaceuticals | Edgewise Therapeutics vs. Inozyme Pharma |
Relmada Therapeutics vs. Cytokinetics | Relmada Therapeutics vs. Edgewise Therapeutics | Relmada Therapeutics vs. Dyne Therapeutics | Relmada Therapeutics vs. Third Harmonic Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |